Stelac Advisory Services LLC Stryker Corp Transaction History

Stelac Advisory Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$271.49 - $305.09 $43,709 - $49,119	-161 Reduced 5.61%	2,709 $826,000
Q1 2023 May 09, 2023	SELL	$246.13 - $285.47 $2,215 - $2,569	-9 Reduced 0.31%	2,870 $819,000
Q4 2022 Feb 14, 2023	BUY	$205.51 - $253.93 $33,498 - $41,390	163 Added 6.0%	2,879 $703,000
Q2 2022 Aug 10, 2022	BUY	$194.09 - $276.37 $360,425 - $513,219	1,857 Added 216.18%	2,716 $540,000
Q1 2022 May 10, 2022	SELL	$245.33 - $277.77 $961,202 - $1.09 Million	-3,918 Reduced 82.02%	859 $230,000
Q4 2021 Feb 14, 2022	BUY	$236.63 - $276.44 $82,583 - $96,477	349 Added 7.88%	4,777 $1.28 Million
Q3 2021 Nov 15, 2021	BUY	$248.9 - $280.09 $41,068 - $46,214	165 Added 3.87%	4,428 $1.17 Million
Q2 2021 Aug 09, 2021	BUY	$242.95 - $267.0 $1.04 Million - $1.14 Million	4,263 New	4,263 $1.11 Million

2,230

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $146B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Stelac Advisory Services LLC, based on Form 13F filings with the SEC.

Stay updated on Stelac Advisory Services LLC with notifications on news.